Wegovy FlexTouch 0.5mg Danish for sale

4 customer reviews
In Stock

Original price was: $439.00.Current price is: $400.00.

In Stock
Add to Wishlist
Add to Wishlist

Did you like this product? Add to favorites now and follow the product.

Add to Wishlist
Add to Wishlist
Have a Question? Ask a Specialist

+1 (408) 459-8146

Low Prices

Price match guarantee

Guaranteed Fitment.

Always the correct part

In-House Experts.

We know our products

Easy Returns.

Quick & Hassle Free

Description

Wegovy FlexTouch 0.5mg Danish for sale

 

WEGOVY® FLEXTOUCH 0.5mg (Danish)

Brand: WEGOVY®

Manufacturer: Novo Nordisk
Active Substance(s): SEMAGLUTIDE
Strength: 2.0mg/1.5ml
Pack Size: 1 x 1.5ml Pen, 4 disposable NovoFine Plus needles
Wegovy is a prescription-only, once weekly weight loss injection which contains Semaglutide. It is taken once a week, and has clinically proven to be an effective weight loss medication. Wegovy can be used by adults who have a body mass index (BMI) over 30 (or a BMI over 27 with at least one weight-related comorbidity (such as high cholesterol, hypertension, type 2 diabetes, obstructive sleep apnoea etc).

 

INFORMATION

WEGOVY® FLEXTOUCH 0.5mg (Danish) Indications for Use

WEGOVY® (semaglutide injection) is a prescription medication used for chronic weight management in adults who are either:

  • Obese (BMI ≥ 30 kg/m²)
  • Overweight (BMI ≥ 27 kg/m²) with weight-related health conditions such as hypertension, type 2 diabetes, or high cholesterol.Wegovy FlexTouch 0.5mg Danish for sale

WEGOVY® works by mimicking the action of GLP-1 (glucagon-like peptide-1), a hormone that helps regulate appetite and food intake. It makes patients feel fuller and reduces hunger. The drug should be used in conjunction with a reduced-calorie diet and increased physical activity.Wegovy FlexTouch 0.5mg Danish for sale

  • Active ingredient: Semaglutide
  • Main function: Suppresses appetite and increases satiety to assist with weight loss
  • Administration: Weekly subcutaneous injection (under the skin)

WEGOVY® FLEXTOUCH 0.5mg (Danish) Dosage Information

WEGOVY® is available in a pre-filled pen and is administered once a week. The dosing schedule begins with a low dose that is gradually increased to the maintenance dose to reduce the likelihood of side effects.Wegovy FlexTouch 0.5mg Danish for sale

  • Starting dose: 0.25 mg once a week
  • Dose escalation:
    • Weeks 1–4: 0.25 mg
    • Weeks 5–8: 0.5 mg
    • Weeks 9–12: 1 mg
    • Weeks 13–16: 1.7 mg
    • Maintenance dose (after Week 16): 2.4 mg weekly
  • Injection sites: Upper arms, thighs, or abdomen, with rotation of sites to avoid repeated injections in the same spot.

Patients should not exceed the recommended dose and must follow a diet and exercise plan set by their healthcare provider during treatment.

WEGOVY® FLEXTOUCH 0.5mg (Danish) Side Effects and Precautions

Like any medication, WEGOVY® may cause side effects. Most are mild and resolve over time as the body adjusts to the medication, but serious side effects may occur.

  • Very common side effects (affects more than 1 in 10 people):
    • Nausea or vomiting
    • Diarrhea
    • Constipation
    • Stomach pain
    • Fatigue
    • Headache

These are often temporary and may improve as treatment continues.

  • Common side effects (affects up to 1 in 10 people):
    • Indigestion and bloating
    • Burping or flatulence
    • Hair loss
    • Reflux or heartburn
    • Injection site reactions (pain, redness, or swelling)
    • Low blood sugar (hypoglycemia) in diabetic patients
  • Serious side effects (may require immediate medical attention):
    • Thyroid tumors or thyroid cancer: Signs include lumps in the neck, hoarseness, trouble swallowing, or shortness of breath. Patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use WEGOVY®.Wegovy FlexTouch 0.5mg Danish for sale
    • Pancreatitis: Symptoms include severe and persistent stomach pain that may radiate to the back.
    • Gallbladder disease: Sudden abdominal or back pain, often accompanied by nausea and vomiting.
    • Allergic reactions: Breathing difficulties, swelling of the face, lips, tongue, or throat, and a rapid heartbeat.
  • Patients should contact their healthcare provider immediately if they experience these symptoms.

Precautions:

  • WEGOVY® is not recommended for individuals with type 1 diabetes or diabetic ketoacidosis.
  • Patients with a history of suicidal thoughts or depression should be closely monitored.
  • Pregnant or breastfeeding women should not use WEGOVY®, as its effects on fetal development and breast milk are unknown.
  • Dehydration may occur due to vomiting or diarrhea. Patients should drink plenty of fluids.

WEGOVY® FLEXTOUCH 0.5mg (Danish) Clinical Studies and Real-World Outcomes

Clinical trials for WEGOVY® showed significant weight loss when combined with a calorie-reduced diet and physical activity. On average, patients experienced 10-15% body weight loss after sustained treatment.

  • Key findings:
    • Weight loss is typically 5-15% of total body weight, depending on adherence to the regimen.
    • Improvements in blood pressurecholesterol levels, and blood sugar control were noted in participants with type 2 diabetes.
    • Patients reported increased satiety and reduced cravings.

WEGOVY® FLEXTOUCH 0.5mg (Danish) Drug Interactions

WEGOVY® may interact with other medications, particularly those that affect blood sugar levels or heart rate. The most common interactions involve diabetes medications.Wegovy FlexTouch 0.5mg Danish for sale

  • Important drug interactions:
    • Insulin and sulfonylureas: Increased risk of hypoglycemia (low blood sugar). Adjustments in diabetic medications may be needed.Wegovy FlexTouch 0.5mg Danish for sale
    • Hypertension and heart failure medications: Consult with a healthcare provider to manage dosing.
    • Medications for HIVADHD, or appetite suppression: Can increase the risk of side effects or reduce WEGOVY®’s effectiveness.

Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs, vitamins, and herbal supplements.

WEGOVY® FLEXTOUCH 0.5mg (Danish) Instructions for Use

WEGOVY® is administered via a single-use pre-filled pen. The injection is easy to self-administer, but patients must be trained by a healthcare professional before first use.

  • Steps to administer:
    1. Prepare the pen: Ensure the solution is clear and colorless. Avoid use if it appears cloudy.
    2. Choose an injection site: Rotate between the abdomenthighs, or upper arms.
    3. Inject: Press the pen against the skin and wait for the yellow bar to stop moving (indicating the injection is complete).
    4. Dispose of the pen: Use a puncture-resistant sharps container to discard used pens.Wegovy FlexTouch 0.5mg Danish for sale

WEGOVY® FLEXTOUCH 0.5mg (Danish) Contraindications and Warnings

  • WEGOVY® is contraindicated in:
    • Patients with a personal or family history of medullary thyroid carcinoma or MEN2.
    • Pregnant or breastfeeding women.Wegovy FlexTouch 0.5mg Danish for sale
    • Individuals allergic to semaglutide or any other ingredients in the product.

Patients should undergo regular monitoring for thyroid function and pancreatitis while using WEGOVY®.Wegovy FlexTouch 0.5mg Danish for sale